SEC Form 4 · accession 0001012975-17-000474
Altimmune, Inc. · ALT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Gill
Director
Period of report
Jun 2, 2017
Accepted (ET)
Jun 6, 2017 · 4:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326190
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 | Jun 2, 2017 | P | 1,000 | $4.3435 | A | 83,224 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
Exhibit 24 - Power of Attorney